Clearstate is an Economist Intelligence business, highly specialised in healthcare research and data, offering in-market insights and business intelligence.
As global demand for covid-19 testing cools further in 2023, how can IVD companies continue to thrive? Discover the core areas of growth in our free report: https://t.co/2fjMRVC8r1 https://t.co/z7bJkzObQn
Lung cancer is the leading cause of cancer mortality in APAC, with annual deaths expected to increase to over 1.8m by 2040. A global IVD company is currently developing its corporate strategy to help tackle the disease. Discover how Clearstate helped them: https://t.co/sCOfkdCcC9
Gain insights into the demand and adoption of different in-vitro diagnostic (IVD) tests for major infectious diseases and plan your market strategy with our Infectious Diseases Trend Monitor. Discover more now: https://t.co/ykCC18oD9Z
Learn more about the Middle East IVD market and opportunities your business can explore in the region with our report:: https://t.co/a3yp5RoT7i
#IVD#invitrodiagnostics#MiddleEast
In dynamic market segments such as infectious disease testing, demand for testing can change rapidly.
Find out how we helped an IVD company track changes in the market and identify which diseases are on an uptick to prioritise development of solutions. https://t.co/VO1WcDJM0I
The Asia-Pacific in-vitro diagnostics (IVD) market is expected to increase at an annual average of 4.4% from 2021 to 2026.
Learn about the latest developments, growth opportunities and trends shaping the IVD market in APAC: https://t.co/50cGMhmq8x
#IVD#invitrodiagnostics
Asian surgical-device companies have captured an increased market share in APAC. They are now exploring opportunities overseas, particularly in South-East Asia. Learn more: https://t.co/IW8DhB4rys
#China#spinesurgery#surgicaldevices
Develop successful pricing and market strategies with robust data, competitive analysis, annual forecasting and budgeting from IVD Gateway Size & Share Plus. Find out more: https://t.co/Y9eHWyaXGk
#IVD#invitrodiagnostics#medtech
The Chinese government is expected to invest more than Rmb 15.6bn in 2023 on infectious diseases prevention and control, targeting diseases including HIV, tuberculosis and other severe infectious diseases such as covid-19.
https://t.co/v9X6bT2v2Q
#china#ivdtrends
The Asia-Pacific in-vitro diagnostics (IVD) market is expected to increase at an annual average of 4.4% from 2021 to 2026. Explore growth opportunities in the region with our latest article. https://t.co/yJB4HWnFwx
#invitrodiagnostics#medtech#pointofcare#TissueDiagnostics
Gain more insights into the surgical treatment of spinal conditions in the Asia-Pacific region. Explore our latest infographic: https://t.co/whIz9LEszi
#surgicaldevices#surgicaltrends#spinesurgery#APAC